Scott B. Ullem is CVP, Chief Financial Officer of Edwards Lifesciences Corp. Currently has a direct ownership of 30,561 shares of EW, which is worth approximately $2.3 Million. The most recent transaction as insider was on Sep 29, 2023, when has been sold 7,255 shares (Common Stock) at a price of $69.54 per share, resulting in proceeds of $504,512. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.6K
0% 3M change
58.77% 12M change
Total Value Held $2.3 Million

Scott B. Ullem Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 29 2023
SELL
Open market or private sale
$504,512 $69.54 p/Share
7,255 Reduced 27.37%
19,248 Common Stock
Sep 29 2023
BUY
Exercise of conversion of derivative security
$266,621 $36.75 p/Share
7,255 Added 21.49%
26,503 Common Stock
Aug 31 2023
SELL
Open market or private sale
$564,366 $77.79 p/Share
7,255 Reduced 27.37%
19,248 Common Stock
Aug 31 2023
BUY
Exercise of conversion of derivative security
$266,621 $36.75 p/Share
7,255 Added 21.49%
26,503 Common Stock
Jul 31 2023
SELL
Open market or private sale
$611,959 $84.35 p/Share
7,255 Reduced 27.37%
19,248 Common Stock
Jul 31 2023
BUY
Exercise of conversion of derivative security
$266,621 $36.75 p/Share
7,255 Added 21.49%
26,503 Common Stock
Jun 30 2023
SELL
Open market or private sale
$676,673 $93.27 p/Share
7,255 Reduced 27.37%
19,248 Common Stock
Jun 30 2023
BUY
Exercise of conversion of derivative security
$266,621 $36.75 p/Share
7,255 Added 21.49%
26,503 Common Stock
May 17 2023
SELL
Bona fide gift
-
8,496 Reduced 30.62%
19,248 Common Stock
May 11 2023
BUY
Grant, award, or other acquisition
-
9,450 Added 25.41%
27,744 Common Stock
May 10 2023
SELL
Open market or private sale
$7,165,353 $88.79 p/Share
80,700 Reduced 81.52%
18,294 Common Stock
May 10 2023
BUY
Exercise of conversion of derivative security
$2,840,640 $35.2 p/Share
80,700 Added 44.91%
98,994 Common Stock
May 08 2023
SELL
Payment of exercise price or tax liability
$148,550 $88.74 p/Share
1,674 Reduced 8.38%
18,294 Common Stock
May 07 2023
SELL
Payment of exercise price or tax liability
$266,574 $88.74 p/Share
3,004 Reduced 13.08%
19,968 Common Stock
May 07 2023
BUY
Exercise of conversion of derivative security
-
6,062 Added 20.88%
22,972 Common Stock
May 04 2023
SELL
Payment of exercise price or tax liability
$38,852 $88.1 p/Share
441 Reduced 2.54%
16,910 Common Stock
May 03 2023
SELL
Payment of exercise price or tax liability
$38,021 $87.81 p/Share
433 Reduced 2.43%
17,351 Common Stock
Feb 21 2023
SELL
Payment of exercise price or tax liability
$26,300 $78.51 p/Share
335 Reduced 1.85%
17,784 Common Stock
Feb 16 2023
BUY
Grant, award, or other acquisition
-
1,941 Added 9.68%
18,119 Common Stock
May 17 2022
SELL
Payment of exercise price or tax liability
$187,351 $95.93 p/Share
1,953 Reduced 6.26%
29,261 Common Stock
May 08 2022
SELL
Payment of exercise price or tax liability
$877,339 $100.52 p/Share
8,728 Reduced 21.85%
31,214 Common Stock
May 08 2022
BUY
Exercise of conversion of derivative security
-
14,831 Added 27.08%
39,942 Common Stock
May 07 2022
SELL
Payment of exercise price or tax liability
$77,601 $100.52 p/Share
772 Reduced 2.98%
25,111 Common Stock
May 04 2022
SELL
Payment of exercise price or tax liability
$46,715 $105.93 p/Share
441 Reduced 1.68%
25,883 Common Stock
May 03 2022
BUY
Grant, award, or other acquisition
-
5,000 Added 15.96%
26,324 Common Stock

Also insider at

BERY
BERRY GLOBAL GROUP, INC. Consumer Cyclical
ILMN
ILLUMINA, INC. Healthcare
SBU

Scott B. Ullem

CVP, Chief Financial Officer
Irvine, CA

Track Institutional and Insider Activities on EW

Follow Edwards Lifesciences Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW